HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 10/31/2012 -- Riverbed Technology, Inc.(NASDAQ:RVBD) announced that it will acquire OPNET Technologies Inc. for about $43 per share, the equity's price target was lowered to $27 from $28 at Wunderlich Securities. The security is down about 22% on a year-over-year basis, but that hasn't swayed near-term call players. The stock's Schaeffer's put/call open interest ratio (SOIR) checks in at 0.69, confirming calls comfortably outpace puts among options expiring within the next three months. This ratio arrives in the 47th annual percentile, meaning short-term traders are slightly more call-heavy toward RVBD than usual.
How Should Investors Trade RVBD Now? Find Out Here
Impax Laboratories (NASDAQ:IPXL) was off its session low, but still down 12% in big volume on disappointing Q3 results. The drugmaker's earnings jumped 85% to 48 cents a share vs. views of 50 cents. Sales climbed 21% to $145.6 million, missing expectations of $164.4 million. Intraday, the stock fell more than 8% below a 23.33 buy point.
How Should Investors React To IPXL Now? Find Out Here
Lexicon Pharmaceuticals, Inc.(NASDAQ:LXRX) shares dropped 4.15% to $2.08. The company, last week, announced that it commenced an offering to sell, subject to market and other conditions, shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. The company has also intends to grant the underwriters a 30-day option to purchase additional shares of common stock to cover over-allotments, if any. All of the shares in the offering are to be sold by Lexicon.
How Should Investors Trade LXRX Now? Find Out Here
Cavium Inc(NASDAQ:CAVM) shares climbed 10.43% to $33.03 in the early hour after the company reported third-quarter net loss of $7.3 million or $0.15 per share, as compared to net income of $6.0 million or $0.12 per share in the same quarter last year. Adjusted net income for the quarter was $7.8 million or $0.15 per share, as compared to $14.4 million or $0.27 per share in the same quarter last year. Net revenues for the quarter grew to $61.1 million from $67.7 million in the same period last year. Analysts expected earnings of $0.11 per share on revenues of $60.69 million for the quarter.
How Should Investors React To CAVM Now? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)